Compounds > imatinib
Page last updated: 2024-08-16

imatinib and 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide

imatinib has been researched along with 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adrián, FJ; Ding, Q; Ding, S; Fabbro, D; Gray, NS; Hur, W; Liu, Y; Manley, P; Mestan, J; Sim, T; Sloan, C; Velentza, A; Zhang, G1
Chu, JJ; Yang, PL1
Botta, M; Crespan, E; Maga, G; Radi, M; Schenone, S; Zanoli, S1
Berellini, G; Buonamici, S; Cotesta, S; Cowan-Jacob, SW; Dodd, S; Drueckes, P; Fabbro, D; Furet, P; Gabriel, T; Groell, JM; Grotzfeld, RM; Hassan, AQ; Henry, C; Iyer, V; Jahnke, W; Jones, D; Lombardo, F; Loo, A; Manley, PW; Marzinzik, AL; Pellé, X; Rummel, G; Salem, B; Schoepfer, J; Warmuth, M; Wylie, AA; Zoller, T1

Other Studies

4 other study(ies) available for imatinib and 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide

ArticleYear
Allosteric inhibitors of Bcr-abl-dependent cell proliferation.
    Nature chemical biology, 2006, Volume: 2, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Line; Cell Line, Transformed; Cell Proliferation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Piperazines; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines

2006
c-Src protein kinase inhibitors block assembly and maturation of dengue virus.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Feb-27, Volume: 104, Issue:9

    Topics: Animals; Chlorocebus aethiops; CSK Tyrosine-Protein Kinase; Cytotoxicity Tests, Immunologic; Dasatinib; Dengue Virus; Fluorescent Antibody Technique, Indirect; Humans; Microscopy, Electron, Transmission; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; RNA Interference; src-Family Kinases; Thiazoles; Vero Cells; Virus Assembly

2007
Dual Src and Abl inhibitors target wild type Abl and the AblT315I Imatinib-resistant mutant with different mechanisms.
    Bioorganic & medicinal chemistry, 2010, Jun-01, Volume: 18, Issue:11

    Topics: Adenosine Triphosphate; Benzamides; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mutant Proteins; Mutation, Missense; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; src-Family Kinases

2010
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1.
    Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18

    Topics: Allosteric Regulation; Animals; Dogs; Drug Discovery; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Models, Molecular; Molecular Structure; Mutation; Niacinamide; Phosphorylation; Protein Conformation; Protein Kinase Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018